$610 Million is the total value of WINDWARD CAPITAL MANAGEMENT CO /CA's 118 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WAB | Exit | WABTEC CORP COM | $0 | – | -2,548 | -100.0% | -0.04% | – |
| CXO | Exit | CONCHO RES INC | $0 | – | -2,216 | -100.0% | -0.05% | – |
| ESRX | Exit | EXPRESS SCRIPTS HOLDING COMPAN | $0 | – | -4,292 | -100.0% | -0.05% | – |
| MAT | Exit | MATTEL INC COM | $0 | – | -30,138 | -100.0% | -0.11% | – |
| DD | Exit | DU PONT E I DE NEMOURS& CO | $0 | – | -10,828 | -100.0% | -0.15% | – |
| LB | Exit | L BRANDS INC | $0 | – | -59,529 | -100.0% | -0.55% | – |
| DOW | Exit | DOW CHEMICAL CO | $0 | – | -195,372 | -100.0% | -2.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-10-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE INC COM USD | 42 | Q3 2023 | 18.7% |
| AMAZON COM INC COM | 42 | Q3 2023 | 8.1% |
| CVS HEALTH CORPORATION | 42 | Q3 2023 | 7.8% |
| SALESFORCE INC | 42 | Q3 2023 | 7.7% |
| NIKE INC CL B | 42 | Q3 2023 | 5.0% |
| ACCENTURE PLC IRELAND SHS CL A | 42 | Q3 2023 | 4.6% |
| COSTCO WHOLESALE CORP-NEW | 42 | Q3 2023 | 4.1% |
| CANADIAN NATL RY CO COM | 42 | Q3 2023 | 3.7% |
| PFIZER INC | 42 | Q3 2023 | 3.7% |
| PEPSICO INC | 42 | Q3 2023 | 2.6% |
View WINDWARD CAPITAL MANAGEMENT CO /CA's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-01-16 |
| 13F-HR | 2023-10-20 |
| 13F-HR | 2023-07-18 |
| 13F-HR | 2023-04-24 |
| 13F-HR | 2023-01-06 |
| 13F-HR | 2022-10-14 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-04-20 |
| 13F-HR | 2022-01-14 |
View WINDWARD CAPITAL MANAGEMENT CO /CA's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.